Silence and Dainippon Sumitomo expand deal
This article was originally published in Scrip
Executive Summary
Silence Therapeutics and Dainippon Sumitomo Pharma have expanded their small interfering RNA (siRNA) delivery collaboration that they initially signed in August last year.